Beyond the Abstract - Fibrin clot inhibitor medication and efficacy of Bacillus Calmette-Guerin for bladder urothelial cancer, by Stephen Boorjian, MD
BERKELEY, CA (UroToday.com) - Intravesical BCG is an immunotherapy that, together with endoscopic resection, represents the current gold standard treatment for patients with high risk non-muscle invasive urothelial carcinoma.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
